The studies evaluated routine clinical practice data from more than 800 hospitals in the US.
Your search for supplemental oxygen returned 4 results
Actemra (tocilizumab) is an interleukin-6 receptor antagonist.
Kineret is an interleukin-1 receptor antagonist.
InflaRx is working to increase supply of the product in the US as quickly as possible.